☰

Ralf Reilmann - Publications

Affiliations: 
Neurology University of Munster, Münster, Nordrhein-Westfalen, Germany 
Area:
Huntington's disease
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

138/214 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Reilmann R, Anderson KE, Feigin A, Tabrizi SJ, Leavitt BR, Stout JC, Piccini P, Schubert R, Loupe P, Wickenberg A, Borowsky B, Rynkowski G, Volkinshtein R, Li T, Savola JM, et al. Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study. The Lancet. Neurology. PMID 38280392 DOI: 10.1016/S1474-4422(23)00454-4  0.338
2023 Saft C, Burgunder JM, Dose M, Jung HH, Katzenschlager R, Priller J, Nguyen HP, Reetz K, Reilmann R, Seppi K, Landwehrmeyer GB. Symptomatic treatment options for Huntington's disease (guidelines of the German Neurological Society). Neurological Research and Practice. 5: 61. PMID 37968732 DOI: 10.1186/s42466-023-00285-1  0.319
2023 Lunven M, Hernandez Dominguez K, Youssov K, Hamet Bagnou J, Fliss R, Vandendriessche H, Bapst B, Morgado G, Remy P, Schubert R, Reilmann R, Busse M, Craufurd D, Massart R, Rosser A, et al. A new approach to digitized cognitive monitoring: validity of the SelfCog in Huntington's disease. Brain Communications. 5: fcad043. PMID 36938527 DOI: 10.1093/braincomms/fcad043  0.344
2022 Hare E, Bachoud-Lévi AC, Reilmann R, Craufurd D, Busse M, Rosser A, McLauchlan D. Cognitive processes of apathy in Huntington's disease show high sensitivity to disease progression. Clinical Parkinsonism & Related Disorders. 7: 100168. PMID 36405870 DOI: 10.1016/j.prdoa.2022.100168  0.335
2020 Gaßner H, Jensen D, Marxreiter F, Kletsch A, Bohlen S, Schubert R, Muratori LM, Eskofier B, Klucken J, Winkler J, Reilmann R, Kohl Z. Correction to: Gait variability as digital biomarker of disease severity in Huntington's disease. Journal of Neurology. PMID 32221775 DOI: 10.1007/S00415-020-09789-1  0.699
2020 Gaßner H, Jensen D, Marxreiter F, Kletsch A, Bohlen S, Schubert R, Muratori LM, Eskofier B, Klucken J, Winkler J, Reilmann R, Kohl Z. Gait variability as digital biomarker of disease severity in Huntington's disease. Journal of Neurology. PMID 32048014 DOI: 10.1007/S00415-020-09725-3  0.743
2019 Reilmann R. Parkinsonism in Huntington's disease. International Review of Neurobiology. 149: 299-306. PMID 31779817 DOI: 10.1016/bs.irn.2019.10.006  0.35
2019 Schaeffer E, Streich S, Wurster I, Schubert R, Reilmann R, Wolfram S, Berg D. How to evaluate effects of occupational therapy - lessons learned from an exploratory randomized controlled trial. Parkinsonism & Related Disorders. 67: 42-47. PMID 31621606 DOI: 10.1016/J.Parkreldis.2019.09.013  0.314
2019 Ross CA, Reilmann R, Cardoso F, McCusker EA, Testa CM, Stout JC, Leavitt BR, Pei Z, Landwehrmeyer B, Martinez A, Levey J, Srajer T, Bang J, Tabrizi SJ. Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories. Movement Disorders Clinical Practice. 6: 541-546. PMID 31538087 DOI: 10.1002/Mdc3.12808  0.366
2019 Medzech S, Sass C, Bohlen S, Lange HW, Koch R, Schubert R, Ringelstein EB, Reilmann R. Impaired Isometric Force Matching in Upper and Lower Limbs Revealed by Quantitative Motor Assessments in Huntington's Disease. Journal of Huntington's Disease. PMID 31450507 DOI: 10.3233/Jhd-190354  0.466
2019 Hohenfeld C, Dogan I, Schubert R, Didszun C, Schöls L, Synofzik M, Giordano IA, Klockgether T, Schulz JB, Reilmann R, Reetz K. Application of Quantitative Motor Assessments in Friedreich Ataxia and Evaluation of Their Relation to Clinical Measures. Cerebellum (London, England). PMID 31441004 DOI: 10.1007/S12311-019-01073-X  0.409
2019 Langbehn DR, Stout JC, Gregory S, Mills JA, Durr A, Leavitt BR, Roos RAC, Long JD, Owen G, Johnson HJ, Borowsky B, Craufurd D, Reilmann R, Landwehrmeyer GB, Scahill RI, et al. Association of CAG Repeats With Long-term Progression in Huntington Disease. Jama Neurology. PMID 31403680 DOI: 10.1001/Jamaneurol.2019.2368  0.394
2019 Bachoud-Lévi AC, Ferreira J, Massart R, Youssov K, Rosser A, Busse M, Craufurd D, Reilmann R, De Michele G, Rae D, Squitieri F, Seppi K, Perrine C, Scherer-Gagou C, Audrey O, et al. International Guidelines for the Treatment of Huntington's Disease. Frontiers in Neurology. 10: 710. PMID 31333565 DOI: 10.3389/Fneur.2019.00710  0.395
2019 van der Plas E, Schubert R, Reilmann R, Nopoulos PC. A Feasibility Study of Quantitative Motor Assessments in Children Using the Q-Motor Suite. Journal of Huntington's Disease. PMID 31256146 DOI: 10.3233/Jhd-190353  0.388
2019 Klehmet J, Beutner S, Hoffmann S, Dornauer M, Paul F, Reilmann R, Brandt AU, Meisel A. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy. Bmc Neurology. 19: 118. PMID 31176377 DOI: 10.1186/S12883-019-1339-X  0.447
2019 Drew CJG, Quinn L, Hamana K, Williams-Thomas R, Marsh L, Dimitropoulou P, Playle R, Griffin BA, Kelson M, Schubert R, Muratori L, Reilmann R, Rosser A, Busse M. Physical ACtivity and Exercise Outcomes in Huntington Disease (PACE-HD): Protocol for a 12-Month Trial Within Cohort Evaluation of a Physical Activity Intervention in People With Huntington Disease. Physical Therapy. PMID 31101920 DOI: 10.1093/Ptj/Pzz075  0.682
2019 Matheis T, Evinger C, Schubert R, Mazzola S, Fels M, Kemper N, Reilmann R, Muratori L. Biological Motion Perception in Huntington's Disease. Journal of Huntington's Disease. PMID 31033464 DOI: 10.3233/Jhd-180337  0.687
2019 Espay AJ, Hausdorff JM, Sánchez-Ferro Á, Klucken J, Merola A, Bonato P, Paul SS, Horak FB, Vizcarra JA, Mestre TA, Reilmann R, Nieuwboer A, Dorsey ER, Rochester L, Bloem BR, et al. A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30901495 DOI: 10.1002/Mds.27671  0.317
2019 Vizcarra JA, Sánchez-Ferro Á, Maetzler W, Marsili L, Zavala L, Lang AE, Martinez-Martin P, Mestre TA, Reilmann R, Hausdorff JM, Dorsey ER, Paul SS, Dexheimer JW, Wissel BD, Fuller RLM, et al. The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30901492 DOI: 10.1002/Mds.27673  0.346
2019 Quarrell OWJ, Nance MA, Nopoulos P, Reilmann R, Oosterloo M, Tabrizi SJ, Furby H, Saft C, Roos RAC, Squitieri F, Landwehrmeyer GB, Burgunder JM. Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30788860 DOI: 10.1002/Mds.27640  0.376
2019 Rieke L, Fels M, Schubert R, Habbel B, Matheis T, Schuldenzucker V, Kemper N, Reilmann R. Activity Behaviour of Minipigs Transgenic for the Huntington Gene. Journal of Huntington's Disease. PMID 30689591 DOI: 10.3233/Jhd-180325  0.381
2019 Reilmann R, McGarry A, Grachev ID, Savola JM, Borowsky B, Eyal E, Gross N, Langbehn D, Schubert R, Wickenberg AT, Papapetropoulos S, Hayden M, Squitieri F, Kieburtz K, Landwehrmeyer GB, et al. Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study. The Lancet. Neurology. 18: 165-176. PMID 30563778 DOI: 10.1016/S1474-4422(18)30391-0  0.407
2018 Winder JY, Roos RAC, Burgunder JM, Marinus J, Reilmann R. Interrater Reliability of the Unified Huntington's Disease Rating Scale-Total Motor Score Certification. Movement Disorders Clinical Practice. 5: 290-295. PMID 30363437 DOI: 10.1002/Mdc3.12618  0.447
2018 Mestre TA, Forjaz MJ, Mahlknecht P, Cardoso F, Ferreira JJ, Reilmann R, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT. Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations. Movement Disorders Clinical Practice. 5: 111-117. PMID 30363393 DOI: 10.1002/Mdc3.12571  0.422
2018 Jeppesen Kragh F, Bruun M, Budtz-Jørgensen E, Hjermind LE, Schubert R, Reilmann R, Nielsen JE, Hasselbalch SG. Quantitative Measurements of Motor Function in Alzheimer's Disease, Frontotemporal Dementia, and Dementia with Lewy Bodies: A Proof-of-Concept Study. Dementia and Geriatric Cognitive Disorders. 46: 168-179. PMID 30257254 DOI: 10.1159/000492860  0.373
2018 Reilmann R, Schubert R, Bohlen S, Sass C. On the rise: Quantitative measures in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 33: 1370-1371. PMID 30230629 DOI: 10.1002/Mds.27469  0.384
2018 Rieke L, Schubert R, Matheis T, Muratori LM, Motlik J, Schramke S, Fels M, Kemper N, Schuldenzucker V, Reilmann R. Vocalisation as a Viable Assessment for Phenotyping Minipigs Transgenic for the Huntington Gene? Journal of Huntington's Disease. 7: 269-278. PMID 30103340 DOI: 10.3233/Jhd-170284  0.708
2018 Reilmann R, Schuldenzucker V. Minipigs as a Large-Brained Animal Model for Huntington's Disease: From Behavior and Imaging to Gene Therapy. Methods in Molecular Biology (Clifton, N.J.). 1780: 241-266. PMID 29856023 DOI: 10.1007/978-1-4939-7825-0_13  0.363
2018 Schuldenzucker V, Schubert R, Muratori LM, Freisfeld F, Rieke L, Matheis T, Schramke S, Motlik J, Kemper N, Radespiel U, Reilmann R. Behavioral Assessment of Stress Compensation in Minipigs Transgenic for the Huntington Gene Using Cortisol Levels: A Proof-of-Concept Study. Journal of Huntington's Disease. 7: 151-161. PMID 29843247 DOI: 10.3233/Jhd-180285  0.703
2018 Valcárcel-Ocete L, Fullaondo A, Alkorta-Aranburu G, García-Barcina M, Roos RAC, Hjermind LE, Saft C, Frontali M, Reilmann R, Rickards H, Zubiaga AM, Aguirre A. Does arterial hypertension influence the onset of Huntington's disease? Plos One. 13: e0197975. PMID 29791508 DOI: 10.1371/Journal.Pone.0197975  0.434
2018 Kieburtz K, Reilmann R, Olanow CW. Huntington's disease: Current and future therapeutic prospects. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29737569 DOI: 10.1002/Mds.27363  0.384
2018 Beckmann H, Bohlen S, Saft C, Hoffmann R, Gerss J, Muratori L, Ringelstein EB, Landwehrmeyer GB, Reilmann R. Objective assessment of gait and posture in premanifest and manifest Huntington disease - A multi-center study. Gait & Posture. 62: 451-457. PMID 29660633 DOI: 10.1016/J.Gaitpost.2018.03.039  0.744
2018 Minkova L, Gregory S, Scahill RI, Abdulkadir A, Kaller CP, Peter J, Long JD, Stout JC, Reilmann R, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease. Neuroimage. Clinical. 17: 312-324. PMID 29527479 DOI: 10.1016/J.Nicl.2017.10.023  0.436
2018 Rieke L, Schubert R, Matheis T, Muratori L, Freisfeld F, Motlik J, Fels M, Kemper N, Schuldenzucker V, Reilmann R. B11 Vocalisation as a viable assessment for minipigs transgenic for the huntington gene Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.63  0.725
2018 Bohlen S, Paty I, Volteau M, Meyer I, Rein W, Kosinski C, Reilmann R. J07 What can we learn from a phase ii study with BN82451B in hd beyond safety and tolerability – clinical versus objective motor measures Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.267  0.412
2018 Delnomdedieu M, Tan Y, Ogden A, Berger Z, Reilmann R. J06 A randomized, double-blind, placebo-controlled phase ii efficacy and safety study of the PDE10A inhibitor PF-02545920 in huntington disease (amaryllis) Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.266  0.384
2018 Reilmann R, Gordon MF, Anderson KE, Feigin A, Tabrizi SJ, Leavitt BR, Stout JC, Piccini P, Rynkowski G, Volkinshtein R, Savola J. J05 Legato-hd study: a phase 2 study assessing the efficacy and safety of laquinimod as a treatment for huntington disease Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.265  0.367
2018 Massart R, Ferreira J, Youssov K, Rosser A, Busse M, Craufurd D, Reilmann R, Michele GD, Rae D, Squitieri F, Seppi K, Burgunder J, Bachoud-Lévi A. H01 Upcoming international guidelines in huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.182  0.376
2018 Jensen D, Gassner H, Spital L, Raulet P, Kletsch A, Bohlen S, Schubert R, Muratori LM, Eskofier B, Klucken J, Winkler J, Reilmann R, Kohl Z. F65 Mobile sensor-based gait analysis provides objective motor assessments in huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.166  0.737
2018 Schubert R, Rosser A, Bachoud-Lévi A, Craufurd D, Reilmann R. F63 Preliminary results from Q-MOTOR/Q-COG analyses in the repair-hd study Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.164  0.419
2018 McMillan I, McLauchlan D, Busse M, Bachoud-Lévi A, Reilmann R, Rosser A, Craufurd D. F57 Psychiatric symptoms in huntington’s disease: correlations between interview and self-report measures in the capit-hd2 beta-testing study Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.158  0.386
2018 McMillan I, McLauchlan D, Busse M, Bachoud-Lévi A, Reilmann R, Rosser A, Craufurd D. F56 Psychiatric symptoms in huntington’s disease: relationship to disease stage in the CAPIT-HD2 beta-testing study Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.157  0.453
2018 Massart R, Busse M, Craufurd D, Reilmann R, Rosser A, Bachoud-Lévi A. F55 Repair-hd project – WP5: preparation for clinical intervention Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.156  0.4
2018 Massart R, Lunven M, Hamet J, Gabadinho A, Reilmann R, Busse M, Craufurd D, Rosser A, Audureau E, Bachoud-Lévi A. F30 Ecog: digitalised assessment of cognitive decline in huntington’s disease (HD) Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.134  0.345
2018 Lange H, Bohlen S, Reilmann R. F06 When and how does manifest hd begin? a comparison of age at onset of motor and non-motor symptoms Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.112  0.359
2017 Schuldenzucker V, Schubert R, Muratori LM, Freisfeld F, Rieke L, Matheis T, Schramke S, Motlik J, Kemper N, Radespiel U, Reilmann R. Behavioral testing of minipigs transgenic for the Huntington gene-A three-year observational study. Plos One. 12: e0185970. PMID 29016656 DOI: 10.1371/Journal.Pone.0185970  0.706
2017 Long JD, Mills JA, Leavitt BR, Durr A, Roos RA, Stout JC, Reilmann R, Landwehrmeyer B, Gregory S, Scahill RI, Langbehn DR, Tabrizi SJ. Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis. Jama Neurology. PMID 28975278 DOI: 10.1001/Jamaneurol.2017.2107  0.411
2017 Reilmann R, Schubert R. Motor outcome measures in Huntington disease clinical trials. Handbook of Clinical Neurology. 144: 209-225. PMID 28947119 DOI: 10.1016/B978-0-12-801893-4.00018-3  0.449
2017 Frost C, Mulick A, Scahill RI, Owen G, Aylward E, Leavitt BR, Durr A, Roos RAC, Borowsky B, Stout JC, Reilmann R, Langbehn DR, Tabrizi SJ, Sampaio C. Design optimization for clinical trials in early-stage manifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28906031 DOI: 10.1002/Mds.27122  0.375
2017 Kragh FJ, Hasselbalch SG, Nielsen JE, Bruun M, Reilmann R, Schubert R. [P4–142]: QUANTITATIVE MEASUREMENTS OF MOTOR FUNCTION IN ALZHEIMER's DISEASE, FRONTOTEMPORAL DEMENTIA, AND LEWY BODY DEMENTIA: A PROOF‐OF‐CONCEPT STUDY Alzheimers & Dementia. 13: 1311. DOI: 10.1016/J.Jalz.2017.06.2008  0.379
2016 Reilmann R. Deutetrabenazine-Not a Revolution but Welcome Evolution for Treating Chorea in Huntington Disease. Jama Neurology. PMID 27749952 DOI: 10.1001/Jamaneurol.2016.3916  0.383
2016 Orth M, Gregory S, Scahill RI, Mayer IS, Minkova L, Klöppel S, Seunarine KK, Boyd L, Borowsky B, Reilmann R, Bernhard Landwehrmeyer G, Leavitt BR, Roos RA, Durr A, Rees G, et al. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease. Human Brain Mapping. PMID 27477323 DOI: 10.1002/Hbm.23332  0.426
2016 Jacobs M, Hart EP, van Zwet EW, Bentivoglio AR, Burgunder JM, Craufurd D, Reilmann R, Saft C, Roos RA. Progression of motor subtypes in Huntington's disease: a 6-year follow-up study. Journal of Neurology. 263: 2080-5. PMID 27435968 DOI: 10.1007/S00415-016-8233-X  0.443
2016 Quinn L, Hamana K, Kelson M, Dawes H, Collett J, Townson J, Roos R, van der Plas AA, Reilmann R, Frich JC, Rickards H, Rosser A, Busse M. A randomized, controlled trial of a multi-modal exercise intervention in Huntington's disease. Parkinsonism & Related Disorders. PMID 27423921 DOI: 10.1016/J.Parkreldis.2016.06.023  0.332
2016 Andrzejewski KL, Dowling AV, Stamler D, Felong TJ, Harris DA, Wong C, Cai H, Reilmann R, Little MA, Gwin JT, Biglan KM, Dorsey ER. Wearable Sensors in Huntington Disease: A Pilot Study. Journal of Huntington's Disease. PMID 27341134 DOI: 10.3233/Jhd-160197  0.477
2016 Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J, Eskofier BM, Merola A, Horak F, Lang AE, Reilmann R, Giuffrida J, Nieuwboer A, Horne M, Little MA, et al. Technology in Parkinson's disease: Challenges and opportunities. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27125836 DOI: 10.1002/Mds.26642  0.38
2016 Keogh R, Frost C, Owen G, Daniel RM, Langbehn DR, Leavitt B, Durr A, Roos RA, Landwehrmeyer GB, Reilmann R, Borowsky B, Stout J, Craufurd D, Tabrizi SJ. Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance. Plos Currents. 8. PMID 26819833 DOI: 10.1371/Currents.Hd.8060298Fac1801B01Ccea6Acc00F97Cb  0.363
2016 Schuldenzucker V, Schubert R, Freisfeld F, Rieke L, Matheis T, Motlik J, Schramke S, Reilmann R. C14 A stress level test as part of an assessment battery for phenotyping minipigs transgenic for huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.94  0.336
2016 Rieke L, Schramke S, Matheis T, Schubert R, Freisfeld F, Motlik J, Schuldenzucker V, Reilmann R. C12 A new setup of the discrimination test as part of an assessment battery for phenotyping minipigs transgenic for huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.92  0.335
2016 Schuldenzucker V, Schubert R, Freisfeld F, Rieke L, Matheis T, Motlik J, Schramke S, Reilmann R. C10 Behavioural phenotyping of minipigs transgenic for the huntington gene Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.90  0.364
2016 Bohlen S, Mühlbäck A, Marquard R, Saß C, Reetz K, Schiefer J, Saft C, Kohl Z, Bonelli R, Münchau A, Klebe S, Weindl A, Storch A, Löhle M, Klopstock T, ... ... Reilmann R, et al. M4 Safety and tolerability of BN82451B in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A102.2-A103. DOI: 10.1136/Jnnp-2016-314597.289  0.341
2016 Papoutsi M, Weiskopf N, Langbehn D, Reilmann R, Rees G, Tabrizi SJ. A17 HD brain-train: neuroplasticity as a target to improve function in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A5.3-A5. DOI: 10.1136/Jnnp-2016-314597.17  0.31
2016 Muratori LM, Evinger L, Reilmann R. F3 Biological motion perception in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A49.2-A49. DOI: 10.1136/Jnnp-2016-314597.138  0.692
2016 Schubert R, Weber N, Reilmann R. F1 Q-COG – a cognitive assessment battery for huntington’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.136  0.421
2016 Jacobs M, Hart EP, Zwet EWv, Bentivoglio AR, Burgunder J, Craufurd D, Reilmann R, Saft C, Roos RA. E2 Progression of motor subtypes in huntington’s disease: a six-year follow-up study Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.128  0.405
2016 Ross CA, Reilmann R. E1 Diagnostic criteria for huntington’s disease based on natural history Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.127  0.471
2016 Gregory S, Klöppel S, Scheller E, Minkova L, Razi A, Durr A, Roos RA, Leavitt BR, Papoutsi M, Landwehrmeyer GB, Reilmann R, Borowsky B, Johnson H, Mills JA, Owen G, et al. D22 Compensation in preclinical huntington’s disease: evidence from the track-on HD study Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.121  0.375
2015 Hoffmann S, Siedler J, Brandt AU, Piper SK, Kohler S, Sass C, Paul F, Reilmann R, Meisel A. Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study. Bmc Neurology. 15: 265. PMID 26701600 DOI: 10.1186/S12883-015-0517-8  0.435
2015 Schramke S, Schuldenzucker V, Schubert R, Frank F, Wirsig M, Ott S, Motlik J, Fels M, Kemper N, Hölzner E, Reilmann R. Behavioral phenotyping of minipigs transgenic for the Huntington gene. Journal of Neuroscience Methods. PMID 26688470 DOI: 10.1016/J.Jneumeth.2015.11.013  0.391
2015 Schubert R, Frank F, Nagelmann N, Liebsch L, Schuldenzucker V, Schramke S, Wirsig M, Johnson H, Kim EY, Ott S, Hölzner E, Demokritov SO, Motlik J, Faber C, Reilmann R. Neuroimaging of a minipig model of Huntington's disease: Feasibility of volumetric, diffusion-weighted and spectroscopic assessments. Journal of Neuroscience Methods. PMID 26658298 DOI: 10.1016/J.Jneumeth.2015.11.017  0.392
2015 Klöppel S, Gregory S, Scheller E, Minkova L, Razi A, Durr A, Roos RA, Leavitt BR, Papoutsi M, Landwehrmeyer GB, Reilmann R, Borowsky B, Johnson H, Mills JA, Owen G, et al. Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study. Ebiomedicine. 2: 1420-9. PMID 26629536 DOI: 10.1016/J.Ebiom.2015.08.002  0.411
2015 Johnson EB, Rees EM, Labuschagne I, Durr A, Leavitt BR, Roos RA, Reilmann R, Johnson H, Hobbs NZ, Langbehn DR, Stout JC, Tabrizi SJ, Scahill RI. The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease. Neuropsychologia. PMID 26519555 DOI: 10.1016/J.Neuropsychologia.2015.10.033  0.361
2015 Holtbernd F, Deppe M, Bachmann R, Mohammadi S, Ringelstein EB, Reilmann R. Deficits in tongue motor control are linked to microstructural brain damage in multiple sclerosis: a pilot study. Bmc Neurology. 15: 190. PMID 26450403 DOI: 10.1186/S12883-015-0451-9  0.403
2015 Reilmann R, Lippross V, Hölzner E, Gigengack F, Bohlen S, Kugel H, Deppe M, Osada N, Lücke M, Riess O, Nguyen HP, Von Hörsten S, Schäfers K, Schäfers M, Jacobs AH, et al. FDG μPET Fails to Detect a Disease-Specific Phenotype in Rats Transgenic for Huntington's Disease – A 15 Months Follow-up Study. Journal of Huntington's Disease. 4: 37-47. PMID 26333256 DOI: 10.3233/Jhd-130084  0.313
2015 Maetzler W, Ellerbrock M, Heger T, Sass C, Berg D, Reilmann R. Digitomotography in Parkinson's disease: a cross-sectional and longitudinal study. Plos One. 10: e0123914. PMID 25902182 DOI: 10.1371/Journal.Pone.0123914  0.369
2015 Sturrock A, Laule C, Wyper K, Milner RA, Decolongon J, Dar Santos R, Coleman AJ, Carter K, Creighton S, Bechtel N, Bohlen S, Reilmann R, Johnson HJ, Hayden MR, Tabrizi SJ, et al. A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 393-401. PMID 25690257 DOI: 10.1002/Mds.26118  0.412
2015 Reilmann R, Rouzade-Dominguez ML, Saft C, Süssmuth SD, Priller J, Rosser A, Rickards H, Schöls L, Pezous N, Gasparini F, Johns D, Landwehrmeyer GB, Gomez-Mancilla B. A randomized, placebo-controlled trial of AFQ056 for the treatment of chorea in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 427-31. PMID 25689146 DOI: 10.1002/Mds.26174  0.366
2014 Sampaio C, Borowsky B, Reilmann R. Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1419-28. PMID 25216371 DOI: 10.1002/Mds.26021  0.39
2014 Reilmann R, Leavitt BR, Ross CA. Huntington's disease: a field on the move. Introduction. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1333-4. PMID 25164859 DOI: 10.1002/Mds.26017  0.344
2014 Reilmann R, Leavitt BR, Ross CA. Diagnostic criteria for Huntington's disease based on natural history. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 1335-41. PMID 25164527 DOI: 10.1002/Mds.26011  0.479
2014 Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ. Huntington disease: natural history, biomarkers and prospects for therapeutics. Nature Reviews. Neurology. 10: 204-16. PMID 24614516 DOI: 10.1038/Nrneurol.2014.24  0.322
2014 Reilmann R, Rouzade-Dominguez M, Saft C, Sussmuth S, Priller J, Rosser A, Rickards H, Schols L, Pezous N, Gasparini F, Landwehrmeyer G, Johns D, Gomez-Mancilla B. N03 Efficacy, Safety, And Tolerability Of Afq056 For The Treatment Of Chorea In Patients With Huntington's Disease Journal of Neurology, Neurosurgery & Psychiatry. 85: A102-A104. DOI: 10.1136/Jnnp-2014-309032.295  0.302
2013 Reilmann R. The pridopidine paradox in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1321-4. PMID 23847099 DOI: 10.1002/Mds.25559  0.394
2013 Reilmann R. Pharmacological treatment of chorea in Huntington's disease-good clinical practice versus evidence-based guideline. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1030-3. PMID 23674480 DOI: 10.1002/Mds.25500  0.371
2013 Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos RA, Borowsky B, Landwehrmeyer B, Frost C, Johnson H, Craufurd D, Reilmann R, Stout JC, Langbehn DR. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. The Lancet. Neurology. 12: 637-49. PMID 23664844 DOI: 10.1016/S1474-4422(13)70088-7  0.328
2013 Hart EP, Marinus J, Burgunder JM, Bentivoglio AR, Craufurd D, Reilmann R, Saft C, Roos RA. Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1142-5. PMID 23495076 DOI: 10.1002/Mds.25422  0.419
2013 van den Bogaard SJ, Dumas EM, Hart EP, Milles J, Reilmann R, Stout JC, Craufurd D, Gibbard CR, Tabrizi SJ, van Buchem MA, van der Grond J, Roos RA. Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up. Ajnr. American Journal of Neuroradiology. 34: 317-22. PMID 22918430 DOI: 10.3174/Ajnr.A3303  0.41
2013 Reilmann R, Holtbernd F, Bachmann R, Mohammadi S, Ringelstein EB, Deppe M. Grasping multiple sclerosis: do quantitative motor assessments provide a link between structure and function? Journal of Neurology. 260: 407-14. PMID 22872165 DOI: 10.1007/S00415-012-6639-7  0.365
2013 Bohlen S, Ekwall C, Hellström K, Vesterlin H, Björnefur M, Wiklund L, Reilmann R. Physical therapy in Huntington's disease--toward objective assessments? European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 389-93. PMID 22672573 DOI: 10.1111/J.1468-1331.2012.03760.X  0.456
2013 Delmaire C, Dumas EM, Sharman MA, van den Bogaard SJ, Valabregue R, Jauffret C, Justo D, Reilmann R, Stout JC, Craufurd D, Tabrizi SJ, Roos RA, Durr A, Lehéricy S. The structural correlates of functional deficits in early huntington's disease. Human Brain Mapping. 34: 2141-53. PMID 22438242 DOI: 10.1002/Hbm.22055  0.344
2013 Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, Hyare H, Langbehn DR, Jones R, Leavitt BR, Roos RA, Durr A, Johnson H, Lehéricy S, Craufurd D, Kennard C, ... ... Reilmann R, et al. Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Human Brain Mapping. 34: 519-29. PMID 22102212 DOI: 10.1002/Hbm.21449  0.331
2013 Weber N, Koch R, Reilmann R. P75Measuring cognitive decline in Huntington's Disease: A longitudinal analysis of the Unified Huntington's Disease Rating Scale (UHDRS) cognitive battery Basal Ganglia. 3: 68. DOI: 10.1016/J.Baga.2013.01.076  0.348
2013 Reilmann R, Bohlen S, Saß C, Bechtel N, Jauffret C, Sturrock A, Coleman A, Read J, Say M, t’Hart E, van den Bogaard S, Archarya T, Scahill R, Johnson H, Borowsky B, et al. Q-motor – Quantitative motor assessments: Potential novel endpoints for clinical trials in pre-manifest and symptomatic Huntington's disease – 36 months longitudinal results from the multicenter TRACK-HD study Basal Ganglia. 3: 67-68. DOI: 10.1016/J.Baga.2013.01.074  0.348
2013 Bohlen S, Weber N, Reilmann R. Huntington's disease – Is fatigue the underlying factor of pathologic glossomotography? Basal Ganglia. 3: 67. DOI: 10.1016/J.Baga.2013.01.073  0.353
2012 Reilmann R. An important step towards translation of stem cell therapies in clinical applications for neurodegenerative diseases and beyond? Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1355-6. PMID 23166927 DOI: 10.1002/Mds.25141  0.307
2012 Reilmann R. Does chromatin modulation provide the first wet biomarker for Huntington's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 27: 473. PMID 22590715 DOI: 10.1002/Mds.24914  0.351
2012 Reilmann R, Rumpf S, Beckmann H, Koch R, Ringelstein EB, Lange HW. Huntington's disease: objective assessment of posture--a link between motor and functional deficits. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 555-9. PMID 22241673 DOI: 10.1002/Mds.24908  0.493
2012 van den Bogaard SJ, Dumas EM, Milles J, Reilmann R, Stout JC, Craufurd D, van Buchem MA, van der Grond J, Roos RA. Magnetization transfer imaging in premanifest and manifest Huntington disease. Ajnr. American Journal of Neuroradiology. 33: 884-9. PMID 22241387 DOI: 10.3174/Ajnr.A2868  0.377
2012 Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, Jones R, Johnson H, Craufurd D, Hicks SL, Kennard C, Landwehrmeyer B, Stout JC, Borowsky B, Scahill RI, et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet. Neurology. 11: 42-53. PMID 22137354 DOI: 10.1016/S1474-4422(11)70263-0  0.334
2012 Bohn E, Bohlen S, Sass C, Bechtel N, Adamou E, Reilmann R, Paul F, Pfueller C. Quantitative Motor Assessment (Q-Motor) in Multiple Sclerosis Patients and Healthy Controls (P01.150) Neurology. 78: P01.150-P01.150. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P01.150  0.367
2012 Reilmann R. Huntington's disease: Towards disease modification - gaps and bridges, facts and opinions Basal Ganglia. 2: 241-248. DOI: 10.1016/J.Baga.2012.09.004  0.463
2011 de Yebenes JG, Landwehrmeyer B, Squitieri F, Reilmann R, Rosser A, Barker RA, Saft C, Magnet MK, Sword A, Rembratt A, Tedroff J. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 10: 1049-57. PMID 22071279 DOI: 10.1016/S1474-4422(11)70233-2  0.432
2011 Vaccarino AL, Sills T, Anderson KE, Biglan K, Borowsky B, Giuliano J, Guttman M, Ho AK, Kennard C, Kupchak P, Landwehrmeyer GB, Michell A, Paulsen JS, Reilmann R, van Kammen DP, et al. Assessment of motor symptoms and functional impact in prodromal and early huntington disease. Plos Currents. 2: RRN1244. PMID 21804956 DOI: 10.1371/Currents.Rrn1244  0.41
2011 Kandasamy M, Reilmann R, Winkler J, Bogdahn U, Aigner L. Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease. Neurology Research International. 2011: 124256. PMID 21766020 DOI: 10.1155/2011/124256  0.32
2011 Sitek EJ, SoÅ‚tan W, Wieczorek D, Schinwelski M, Robowski P, Reilmann R, GuziÅ„ska K, Harciarek M, Krysa W, SÅ‚awek J. Self-awareness of motor dysfunction in patients with Huntington's disease in comparison to Parkinson's disease and cervical dystonia. Journal of the International Neuropsychological Society : Jins. 17: 788-95. PMID 21729402 DOI: 10.1017/S1355617711000725  0.429
2011 Reilmann R, Bohlen S, Kirsten F, Ringelstein EB, Lange HW. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2267-73. PMID 21661053 DOI: 10.1002/Mds.23816  0.504
2011 Reilmann R. Progression of premanifest and early Huntington's disease detectable after 1 year—does TRACK-HD open the door to disease-modifying trials in HD and beyond? Movement Disorders : Official Journal of the Movement Disorder Society. 26: 605. PMID 21648124 DOI: 10.1002/Mds.23710  0.425
2011 López-Sendón JL, Royuela A, Trigo P, Orth M, Lange H, Reilmann R, Keylock J, Rickards H, Piacentini S, Squitieri F, Landwehrmeyer B, Witjes-Ane MN, Jurgens CK, Roos RA, Abraira V, et al. What is the impact of education on Huntington's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1489-95. PMID 21432905 DOI: 10.1002/Mds.23385  0.387
2011 Tabrizi SJ, Scahill RI, Durr A, Roos RA, Leavitt BR, Jones R, Landwehrmeyer GB, Fox NC, Johnson H, Hicks SL, Kennard C, Craufurd D, Frost C, Langbehn DR, Reilmann R, et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. The Lancet. Neurology. 10: 31-42. PMID 21130037 DOI: 10.1016/S1474-4422(10)70276-3  0.477
2011 Beckmann H, Rumpf S, Bechtel N, Lange H, Saft C, Hoffmann R, Kraus P, Barth K, Trautmann S, Landwehrmeyer B, Reilmann R. Gait and posture in pre-manifest and symptomatic huntington's disease Klinische Neurophysiologie. 42. DOI: 10.1055/s-0031-1272717  0.318
2011 Rumpf S, Bohlen S, Bechtel N, Koch R, Lange H, Reilmann R. Postural assessement in dynamic posturography - a useful motor phenotype measure for presymptomatic and manifest Huntington disease? Klinische Neurophysiologie. 42. DOI: 10.1055/s-0031-1272714  0.324
2011 Horst S, Bohlen S, Lange H, Reilmann R. Impaired isometric force coordination in Huntington's disease Klinische Neurophysiologie. 42. DOI: 10.1016/J.Baga.2013.01.072  0.411
2011 Reilmann R. Progression of premanifest and early Huntington's disease detectable after 1 year-Does TRACK-HD open the door to disease-modifying trials in HD and beyond? Movement Disorders. 26: 605. DOI: 10.1002/mds.23710  0.313
2010 Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, ... ... Reilmann R, et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 75: 2150-60. PMID 21068430 DOI: 10.1212/Wnl.0B013E3182020123  0.506
2010 Sturrock A, Laule C, Decolongon J, Dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR. Magnetic resonance spectroscopy biomarkers in premanifest and early Huntington disease. Neurology. 75: 1702-10. PMID 21060093 DOI: 10.1212/Wnl.0B013E3181Fc27E4  0.441
2010 Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW. Grasping premanifest Huntington's disease - shaping new endpoints for new trials. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2858-62. PMID 20818671 DOI: 10.1002/Mds.23300  0.476
2010 Reilmann R, Bohlen S, Klopstock T, Bender A, Weindl A, Saemann P, Auer DP, Ringelstein EB, Lange HW. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2195-202. PMID 20645403 DOI: 10.1002/Mds.23243  0.502
2010 Rumpf S, Bohlen S, Bechtel N, Koch R, Lange H, Reilmann R. F16 Postural assessment in dynamic posturography—a useful motor phenotype measure for presymptomatic and manifest Huntington's disease? Journal of Neurology, Neurosurgery & Psychiatry. 81: A27.3-A28. DOI: 10.1136/jnnp.2010.222620.16  0.301
2010 Rumpf S, Bohlen S, Bechtel N, Koch R, Lange H, Reilmann R. F15 Balance control in Huntington's disease: is the berg balance scale a useful test for clinical and quantitative motor assessment? Journal of Neurology, Neurosurgery & Psychiatry. 81: A27.2-A27. DOI: 10.1136/jnnp.2010.222620.15  0.319
2010 Sitek EJ, Sołtan W, Wieczorek D, Schinwelski M, Robowski P, Reilmann R, Krysa W, Sławek J. F11 Self-awareness of involuntary movements and daily living disability in huntington's disease in comparison to Parkinson's disease and cervical dystonia Journal of Neurology, Neurosurgery & Psychiatry. 81: A26.1-A26. DOI: 10.1136/Jnnp.2010.222620.11  0.378
2009 Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, Kennard C, Hicks SL, Fox NC, Scahill RI, Borowsky B, Tobin AJ, Rosas HD, Johnson H, Reilmann R, et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet. Neurology. 8: 791-801. PMID 19646924 DOI: 10.1016/S1474-4422(09)70170-X  0.477
2009 Rumpf S, Bohlen S, Ekwall C, Lange H, Reilmann R. Motor exam in Huntington's disease: is one leg stand a useful test for clinical and quantitative motor assessment? Aktuelle Neurologie. 36. DOI: 10.1055/s-0029-1238523  0.332
2009 Beckmann H, Rumpf S, Bechtel N, Lange H, Saft C, Hoffmann R, Kraus P, Barth K, Trautmann S, Landwehrmeyer B, Reilmann R. Objective motor phenotype assessment of gait and posture in pre-manifest and symptomatic Huntington's disease Aktuelle Neurologie. 36. DOI: 10.1055/s-0029-1238522  0.391
2009 Say M, Bechtel N, Sturrock A, van den Bogaard S, Jauffret C, Bohlen S, Langbehn D, Mills J, Archarya T, Johnson H, Borowsky B, Durr A, Leavitt B, Roos R, Tabrizi S, ... ... Reilmann R, et al. Quantitative motor phenotype assessment in pre-manifest and symptomatic Huntington's disease: tongue force analysis differentiates between disease stages and provides high phenotype correlation. Cross sectional results from the TRACK-HD Study Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238518  0.342
2009 Bechtel N, Jauffret C, Say M, Sturrock A, van den Bogaard S, Mills J, Archarya T, Langbehn D, Johnson H, Borowsky B, Durr A, Leavitt B, Roos R, Stout J, Tabrizi S, ... ... Reilmann R, et al. Finger tapping as an objective motor phenotype marker in pre-manifest and symptomatic Huntington's disease – cross-sectional results from the TRACK-HD Study Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238474  0.307
2008 Rumpf S, Beckmann H, Bohlen S, Bechtel N, Kraus P, Lange H, Reilmann R. Impairments of postural control in patient's with Huntington's disease while sitting – a new motor phenotype biomarker? Aktuelle Neurologie. 35. DOI: 10.1055/s-0028-1086866  0.331
2005 Bender A, Auer DP, Merl T, Reilmann R, Saemann P, Yassouridis A, Bender J, Weindl A, Dose M, Gasser T, Klopstock T. Creatine supplementation lowers brain glutamate levels in Huntington's disease. Journal of Neurology. 252: 36-41. PMID 15672208 DOI: 10.1007/S00415-005-0595-4  0.369
2005 Kirsten F, Bohlen S, Sommer J, Merl T, Saemann P, Klopstock T, Bender A, Dose M, Weindl A, Auer D, Ringelstein E, Reilmann R. Altered isometric force control during object release in patients with Huntington's Disease Aktuelle Neurologie. 32. DOI: 10.1055/S-2005-919363  0.389
2005 Reilmann R. Motor deficits as biomarkers in Huntington's disease: Perspectives for neuroacanthocytosis syndromes Neuroacanthocytosis Syndromes. 233-242. DOI: 10.1007/1-4020-2898-9_26  0.302
2003 Muratori LM, Reilmann R, Gordon AM. Coordination of fingertip forces during precision grasping in multiple system atrophy. Neuropsychologia. 41: 1498-508. PMID 12849768 DOI: 10.1016/S0028-3932(03)00092-7  0.73
2003 Salimi I, Frazier W, Reilmann R, Gordon AM. Selective use of visual information signaling objects' center of mass for anticipatory control of manipulative fingertip forces. Experimental Brain Research. 150: 9-18. PMID 12698211 DOI: 10.1007/S00221-003-1394-8  0.733
2003 Flöel A, Reilmann R, Frese A, Lüdemann P. Anticonvulsants for Creutzfeldt-Jakob disease? Lancet. 361: 224. PMID 12547547 DOI: 10.1016/S0140-6736(03)12273-8  0.379
2001 Reilmann R, Gordon AM, Henningsen H. Initiation and development of fingertip forces during whole-hand grasping. Experimental Brain Research. 140: 443-52. PMID 11685397 DOI: 10.1007/S002210100838  0.497
2001 Reilmann R, Kirsten F, Quinn L, Henningsen H, Marder K, Gordon AM. Objective assessment of progression in Huntington's disease: a 3-year follow-up study. Neurology. 57: 920-4. PMID 11552034 DOI: 10.1212/Wnl.57.5.920  0.616
2001 Quinn L, Reilmann R, Marder K, Gordon AM. Altered movement trajectories and force control during object transport in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 16: 469-80. PMID 11391741 DOI: 10.1002/Mds.1108  0.56
2000 Gordon AM, Quinn L, Reilmann R, Marder K. Coordination of prehensile forces during precision grip in Huntington's disease. Experimental Neurology. 163: 136-48. PMID 10785452 DOI: 10.1006/Exnr.2000.7348  0.596
1999 Gordon AM, Reilmann R. Getting a grasp on research: does treatment taint testing of parkinsonian patients? Brain : a Journal of Neurology. 122: 1597-8. PMID 10430842 DOI: 10.1093/Brain/122.8.1597  0.535
1995 Reilmann R, Rolf LH, Lange HW. Decreased plasma alanine and isoleucine in Huntington's disease. Acta Neurologica Scandinavica. 91: 222-4. PMID 7793240 DOI: 10.1111/J.1600-0404.1995.Tb00438.X  0.306
Low-probability matches (unlikely to be authored by this person)
2015 Klöppel S, Gregory S, Scheller E, Minkova L, Razi A, Durr A, Roos RAC, Leavitt BR, Papoutsi M, Landwehrmeyer GB, Reilmann R, Borowsky B, Johnson H, Mills JA, Owen G, et al. Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study Ebiomedicine. DOI: 10.1016/j.ebiom.2015.08.002  0.299
2012 Horst S, Sass C, Bohlen S, Lange H, Reilmann R. I07 Impaired isometric force coordination in Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 83: A34.3-A34. DOI: 10.1136/jnnp-2012-303524.106  0.299
2013 Horst S, Saß C, Bohlen S, Lange H, Reilmann R. Impaired isometric force coordination in Huntington's disease Basal Ganglia. 3: 66-67. DOI: 10.1016/j.baga.2013.01.072  0.298
2005 Reilmann R, Imai T, Ringelstein EB, Gaubitz M, Niederstadt TU, Paulus W, Husstedt IW. Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: a 4 year follow up. Journal of Neurology, Neurosurgery, and Psychiatry. 76: 1304-5. PMID 16107375 DOI: 10.1136/Jnnp.2004.057588  0.297
2015 Schaeffer E, Maetzler W, Liepelt-Scarfone I, Sass C, Reilmann R, Berg D. Quantitative motor assessment of dyskinesias in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 25712401 DOI: 10.1007/S00702-015-1383-7  0.297
2018 Woodgate S, Busse M, Clinch S, Bachoud-Lévi A, Reilmann R, Craufurd D, Rosser A. F67 Optimising discriminative ability of performance-based assessments in hd Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.168  0.296
2018 Busse M, Quinn L, Drew C, Williams-Thomas R, Dimitropoulou P, Playle R, Hamana K, Griffin BA, Reilmann R, Kelson M, Rosser A. J09 A new trial design for evaluating exercise outcomes in huntington’s disease Clinical Therapeutics. DOI: 10.1136/Jnnp-2018-Ehdn.269  0.295
2009 Rohm S, Bechtel N, Beckmann H, Sturrock A, van den Bogaard S, Say M, Jauffret C, Mills J, Archarya T, Langbehn D, Johnson H, Borowsky B, Durr A, Leavitt B, Roos R, ... ... Reilmann R, et al. Sensitivity of gait analysis to detect motor phenotype in pre-manifest and manifest Huntington's disease – cross-sectional results from the TRACK-HD Study Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238520  0.294
2013 Süßmuth SD, Saft C, Reilmann R, Orth M, Landwehrmeyer GB. Huntington's disease update | Neues zur Huntington-Krankheit Aktuelle Neurologie. 40: 377-392. DOI: 10.1055/s-0033-1345194  0.29
1997 Reilmann R, Rolf LH, Lange HW. Huntington's disease: N-methyl-D-aspartate receptor coagonist glycine is increased in platelets. Experimental Neurology. 144: 416-9. PMID 9168841 DOI: 10.1006/Exnr.1997.6428  0.288
2016 Quinn L, Hamana K, Kelson M, Dawes H, Collett J, Townson J, Roos R, Plas Avd, Reilmann R, Frich J, Rickards H, Rosser A, Busse M. M12 A randomised, controlled trial of a 12 week multi-modal exercise intervention in huntington’s disease Journal of Neurology, Neurosurgery & Psychiatry. 87: A105.2-A106. DOI: 10.1136/Jnnp-2016-314597.297  0.288
2014 Bank PJ, van Rooijen DE, Marinus J, Reilmann R, van Hilten JJ. Force modulation deficits in complex regional pain syndrome: a potential role for impaired sense of force production. European Journal of Pain (London, England). 18: 1013-23. PMID 24382670 DOI: 10.1002/J.1532-2149.2013.00446.X  0.287
2020 Claassen DO, Corey-Bloom J, Dorsey ER, Edmondson M, Kostyk SK, LeDoux MS, Reilmann R, Rosas HD, Walker F, Wheelock V, Svrzikapa N, Longo KA, Goyal J, Hung S, Panzara MA. Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington disease. Neurology. Genetics. 6: e430. PMID 32548276 DOI: 10.1212/Nxg.0000000000000430  0.282
1994 Reilmann R, Rolf LH, Lange HW. Huntington's disease: the neuroexcitotoxin aspartate is increased in platelets and decreased in plasma. Journal of the Neurological Sciences. 127: 48-53. PMID 7699391 DOI: 10.1016/0022-510X(94)90134-1  0.279
2018 Claassen D, Edmondson M, Reilmann R, Svrzikapa N, Longo K, Goyal J, Hung S, Panzara M. J04 A prospective observational study of the frequency of single nucleotide polymorphisms (SNP) in patients with huntington’s disease (hd) Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.264  0.279
2013 Squitieri F, Landwehrmeyer B, Reilmann R, Rosser A, de Yebenes JG, Prang A, Ivkovic J, Bright J, Rembratt A. One-year safety and tolerability profile of pridopidine in patients with Huntington disease. Neurology. 80: 1086-94. PMID 23446684 DOI: 10.1212/Wnl.0B013E3182886965  0.278
2010 Bechtel N, Acharya T, Sturrock A, Jauffret C, Say MJ, Patel A, Read JE, t'Hart E, van den Bogaard SJA, Dürr A, Leavitt BR, Roos RAC, Langbehn DR, Tabrizi SJ, Reilmann R. F14 Speeded tapping assesses progression of huntington's disease within one year—results from the track-HD study Journal of Neurology, Neurosurgery & Psychiatry. 81: A27.1-A27. DOI: 10.1136/jnnp.2010.222620.14  0.277
2010 Squitieri F, Landwehrmeyer GB, Garcia de Yebenes J, Reilmann R, Rosser A, Sword A, Rembratt Å, Tedroff J. L05 Huntexil (pridopidine) improves voluntary motor function in patients with Huntington's disease: results from the phase 3 study MermaiHD Journal of Neurology, Neurosurgery & Psychiatry. 81: A49-A49. DOI: 10.1136/Jnnp.2010.222687.5  0.275
2022 Bird TD, Lange H, Cruickshank T, Dose M, Eddy C, Oosterloo M, Paulsen JS, Reilmann R, Rickards H, Roos RAC, Weindl A. Reader Response: Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease. Neurology. 98: 514-515. PMID 35314515 DOI: 10.1212/WNL.0000000000200161  0.274
2009 Wansing M, Holtbernd F, Bachmann R, Reilmann R. Assessment of motor phenotype in Amyotrophic Lateral Sclerosis using a force plate – a new biomarker for clinical studies? Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238901  0.273
2004 Konrad C, Vollmer-Haase J, Gaubitz M, Nabavi DG, Reilmann R, Knecht S. Fracture of the odontoid process complicating tardive dystonia. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 983-5. PMID 15300672 DOI: 10.1002/Mds.20122  0.272
2022 Lemoine L, Lunven M, Fraisse N, Youssov K, Bapst B, Morgado G, Reilmann R, Busse M, Craufurd D, Rosser A, de Gardelle V, Bachoud-Lévi AC. The striatum in time production: The model of Huntington's disease in longitudinal study. Neuropsychologia. 179: 108459. PMID 36567007 DOI: 10.1016/j.neuropsychologia.2022.108459  0.272
2009 Reilmann R. Grip-force analysis in Huntington's disease - A biomarker for clinical trials? Sensorimotor Control of Grasping: Physiology and Pathophysiology. 326-332. DOI: 10.1017/CBO9780511581267.024  0.272
2007 Holtbernd F, Wansing M, Bachmann R, Deppe M, Ringelstein E, Reilmann R. Assessment of motor phenotype in Multiple Sclerosis using a force plate – a new biomarker for clinical studies? Aktuelle Neurologie. 34. DOI: 10.1055/S-2007-987992  0.271
2018 Papoutsi M, Magerkurth J, Josephs O, Pepes S, Ibitoye T, Reilmann R, Weiskopf N, Langbehn D, Rees G, Tabrizi SJ. J12 HD brain-train: enhancing neural plasticity using real-time FMRI neurofeedback training Journal of Neurology, Neurosurgery, and Psychiatry. 89. DOI: 10.1136/Jnnp-2018-Ehdn.272  0.268
2014 Reilmann R, Squitieri F, Priller J, Saft C, Mariotti C, Sussmuth S, Nemeth A, Tabrizi S, Quarrell O, Craufurd D, Rickards H, Rosser A, Darpo B, Tessari M, Szynol A, et al. N02 Safety And Tolerability Of Selisistat For The Treatment Of Huntington's Disease: Results From A Randomised, Double-blind, Placebo-controlled Phase Ii Trial Journal of Neurology, Neurosurgery & Psychiatry. 85: A102-A102. DOI: 10.1136/Jnnp-2014-309032.294  0.265
2021 Guttman M, Pedrazzoli M, Ponomareva M, Pelletier M, Townson L, Mukelabai K, Levine A, Nordström AL, Reilmann R, Burgunder JM. The Impact of Upcoming Treatments in Huntington's Disease: Resource Capacity Limitations and Access to Care Implications. Journal of Huntington's Disease. PMID 33843690 DOI: 10.3233/JHD-200462  0.263
2019 Gordon MF, Grachev ID, Mazeh I, Dolan Y, Reilmann R, Loupe PS, Fine S, Navon-Perry L, Gross N, Papapetropoulos S, Savola JM, Hayden MR. Quantification of Motor Function in Huntington Disease Patients Using Wearable Sensor Devices. Digital Biomarkers. 3: 103-115. PMID 32095771 DOI: 10.1159/000502136  0.26
2010 Bohlen S, Ekwall C, Wiklund L, Rumpf S, Reilmann R. F12 Test-retest reliability of objective measures of posture, gait and clinical scales in huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 81: A26.2-A26. DOI: 10.1136/jnnp.2010.222620.12  0.26
2007 Wansing M, Holtbernd F, Bachmann R, Deppe M, Reilmann R. Objective assessment of motor dysfunction in ALS using grip force and 3D position analysis – new biomarkers for clinical studies? Aktuelle Neurologie. 34. DOI: 10.1055/S-2007-987974  0.257
2017 Rohrbach S, Buettner F, Pollex D, Mathmann P, Weinhold L, Schubert R, Reilmann R. Quantitative examination of isometric tongue protrusion forces in children with Orofacial dysfunctions (OFD) or myofunctional disorders. Journal of Oral Rehabilitation. PMID 29230834 DOI: 10.1111/Joor.12598  0.256
2021 Woodgate S, Morgan-Jones P, Clinch S, Drew C, Playle R, Bennasar M, Hicks Y, Holt C, Bachoud-Lévi AC, Massart R, Craufurd D, Kirby N, Hamana K, Schubert R, Reilmann R, et al. Objectively characterizing Huntington's disease using a novel upper limb dexterity test. Journal of Neurology. PMID 33555419 DOI: 10.1007/s00415-020-10375-8  0.254
2013 Crawford HE, Hobbs NZ, Keogh R, Langbehn DR, Frost C, Johnson H, Landwehrmeyer B, Reilmann R, Craufurd D, Stout JC, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Scahill RI, et al. Corpus callosal atrophy in premanifest and early Huntington's disease. Journal of Huntington's Disease. 2: 517-26. PMID 25062736 DOI: 10.3233/Jhd-130077  0.251
2020 Moscovich M, Heinzel S, Postuma RB, Reilmann R, Klockgether T, Jacobi H, Höglinger G, Berg D. How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders? Parkinsonism & Related Disorders. PMID 33039276 DOI: 10.1016/j.parkreldis.2020.10.003  0.25
2009 Holtbernd F, Deppe M, Bachmann R, Reilmann R. Objective motor phenotype assessment in multiple sclerosis: deficits in grip force coordination correlate to changes in diffusion tensor imaging Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238399  0.249
2022 Teismann H, Schubert R, Reilmann R, Berger K. Effects of age and sex on outcomes of the Q-Motor speeded finger tapping and grasping and lifting tests-findings from the population-based BiDirect Study. Frontiers in Neurology. 13: 965031. PMID 36247774 DOI: 10.3389/fneur.2022.965031  0.249
2016 Schubert R, Freisfeld F, Johnson H, Kim ER, Nagelmann N, Motlik J, Schramke S, Schuldenzucker V, Rieke L, Matheis T, Wirsig M, Faber C, Reilmann R. C15 Standard brain template and multi-atlas based segmentation of tghd minipig brain Journal of Neurology, Neurosurgery & Psychiatry. 87: A32.1-A32. DOI: 10.1136/Jnnp-2016-314597.95  0.247
2015 Angus D, Herd C, Stone C, Stout J, Wieler M, Reilmann R, Ritchie CW, Dorsey ER, Helles K, Kayson E, Oakes D, Rosas HD, Vaughan C, Panegyres PK, Ames D, et al. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: A phase 2, randomised, double-blind, placebo-controlled trial The Lancet Neurology. 14: 39-47. PMID 25467848 DOI: 10.1016/S1474-4422(14)70262-5  0.245
2016 Reilmann R. A10 HD minipigs – behavioural and imaging protocols transitioning into preclinical trials Journal of Neurology, Neurosurgery, and Psychiatry. 87. DOI: 10.1136/Jnnp-2016-314597.10  0.238
2007 Bechtel N, Haberkamp C, Beckmann H, Baune B, Zwanzger P, Arolt V, Reilmann R. Motor phenotype assessment in patients with depressive disorders using isometric tongue force analysis – a readout for clinical studies? Aktuelle Neurologie. 34. DOI: 10.1055/s-2007-987755  0.237
2021 Lunven M, Hamet Bagnou J, Youssov K, Gabadinho A, Fliss R, Montillot J, Audureau E, Bapst B, Morgado G, Reilmann R, Schubert R, Busse M, Craufurd D, Massart R, Rosser A, et al. Cognitive decline in Huntington's disease in the Digitalized Arithmetic Task (DAT). Plos One. 16: e0253064. PMID 34424902 DOI: 10.1371/journal.pone.0253064  0.233
2014 Papoutsi M, Weiskopf N, Langbehn D, Reilmann R, Rees G, Tabrizi S. J02 Brain Training in HD: Enhancing Neural Plasticity using Real-time FMRI Neurofeedback Training Journal of Neurology, Neurosurgery & Psychiatry. 85: A65-A66. DOI: 10.1136/Jnnp-2014-309032.185  0.227
2017 Papoutsi M, Weiskopf N, Langbehn D, Reilmann R, Rees G, Tabrizi SJ. Stimulating neural plasticity with real-time fMRI neurofeedback in Huntington's disease: A proof of concept study. Human Brain Mapping. PMID 29239063 DOI: 10.1002/hbm.23921  0.224
2010 Delmaire C, Dumas EM, Sharman M, van den Bogaard SJA, Valabregue R, Jauffret C, Reilmann R, Stout JC, Craufurd D, Tabrizi SJ, Roos RAC, Lehéricy S, Dürr A. I06 Correlations between structural damage and functional deficits in early Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 81: A37.2-A37. DOI: 10.1136/jnnp.2010.222679.6  0.221
2006 Bachmann R, Reilmann R, Schwindt W, Kugel H, Heindel W, Krämer S. FLAIR imaging for multiple sclerosis: a comparative MR study at 1.5 and 3.0 Tesla. European Radiology. 16: 915-21. PMID 16365731 DOI: 10.1007/S00330-005-0070-8  0.217
2012 Gelderblom H, Fischer W, Landwehrmeyer B, McLean T, Reilmann R, Saft C, Süssmuth S, Priller J. Q10 Action-HD: a randomised, double-blind, placebo-controlled prospective crossover trial investigating the efficacy and safety of bupropion in Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 83: A57.3-A58. DOI: 10.1136/jnnp-2012-303524.180  0.213
2006 Wansing M, Holtbernd F, Bohlen S, Kirsten F, Bachmann R, Deppe M, Reilmann R. Assessment of isometric tongue forces – an objective and quantitative surrogate marker for amyotrophic lateral sclerosis? Aktuelle Neurologie. 33. DOI: 10.1055/s-2006-953335  0.213
2008 Horváth R, Reilmann R, Holinski-Feder E, Ringelstein EB, Klopstock T. The role of complex I genes in MELAS: a novel heteroplasmic mutation 3380G>A in ND1 of mtDNA. Neuromuscular Disorders : Nmd. 18: 553-6. PMID 18590963 DOI: 10.1016/J.Nmd.2008.05.002  0.211
2005 Reilmann R, Kirsten F, Saemann P, Bohlen S, Sommer J, Klopstock T, Bender A, Dose M, Weindl A, Auer D, Ringelstein EB. Huntington'sche Krankheit: Variabilität isometrischer Greifkräfte als Surrogate Marker für klinischen Studien Aktuelle Neurologie. 32. DOI: 10.1055/S-2005-919187  0.211
2023 Roussakis AA, Gennaro M, Gordon MF, Reilmann R, Borowsky B, Rynkowski G, Lao-Kaim NP, Papoutsou Z, Savola JM, Hayden MR, Owen DR, Kalk N, Lingford-Hughes A, Gunn RN, Searle G, et al. A PET-CT study on neuroinflammation in Huntington's disease patients participating in a randomized trial with laquinimod. Brain Communications. 5: fcad084. PMID 37020532 DOI: 10.1093/braincomms/fcad084  0.198
2013 Hölzner E, Baxa M, Nagelmann N, Marcegaglia M, Weber N, Göpfert N, Benner S, Saß C, Faber C, Motlik J, Reilmann R. TRACK-tgHD Minipig – Introduction of a longitudinal tgHD Minipig phenotyping study using MRI, motor and cognitive endpoints Basal Ganglia. 3: 44. DOI: 10.1016/j.baga.2013.01.016  0.198
2018 Saft C, Bonelli RM, Burgunder J, Dose M, Epplen JT, Jung HH, Priller J, Reilmann R, Rudnik S, Seppi K, Landwehrmeyer GB. Leitlinien „Chorea/Morbus Huntington“ für die deutschsprachigen Länder neu überarbeitet Aktuelle Neurologie. 45: 570-585. DOI: 10.1055/A-0676-8477  0.198
2021 Kegelmeyer DA, Kostyk SK, Fritz NE, Scharre DW, Young GS, Tan Y, Schubert R, Reilmann R, Kloos AD. Immediate effects of treadmill walking in individuals with Lewy body dementia and Huntington's disease. Gait & Posture. 86: 186-191. PMID 33756407 DOI: 10.1016/j.gaitpost.2021.03.016  0.198
2017 McColgan P, Gregory S, Razi A, Seunarine KK, Gargouri F, Durr A, Roos RA, Leavitt BR, Scahill RI, Clark CA, Tabrizi SJ, Rees G, Coleman A, Decolongon J, ... ... Reilmann R, et al. White matter predicts functional connectivity in premanifest Huntington's disease. Annals of Clinical and Translational Neurology. 4: 106-118. PMID 28168210 DOI: 10.1002/Acn3.384  0.197
2023 Saft C, Burgunder JM, Dose M, Jung HH, Katzenschlager R, Priller J, Nguyen HP, Reetz K, Reilmann R, Seppi K, Landwehrmeyer GB. Differential diagnosis of chorea (guidelines of the German Neurological Society). Neurological Research and Practice. 5: 63. PMID 37993913 DOI: 10.1186/s42466-023-00292-2  0.192
2022 Antikainen E, Njoum H, Kudelka J, Branco D, Rehman RZU, Macrae V, Davies K, Hildesheim H, Emmert K, Reilmann R, Janneke van der Woude C, Maetzler W, Ng WF, O'Donnell P, Van Gassen G, et al. Assessing fatigue and sleep in chronic diseases using physiological signals from wearables: A pilot study. Frontiers in Physiology. 13: 968185. PMID 36452041 DOI: 10.3389/fphys.2022.968185  0.191
2010 Sturrock A, Laule C, Decolongon J, dar Santos R, Coleman AJ, Creighton S, Bechtel N, Reilmann R, Hayden MR, Tabrizi SJ, Mackay AL, Leavitt BR. H06 Cross sectional and longitudinal 3T magnetic resonance spectroscopy in a TRACK-HD cohort of individuals with premanifest and early Huntington's disease Journal of Neurology, Neurosurgery & Psychiatry. 81: A35.2-A35. DOI: 10.1136/Jnnp.2010.222653.6  0.188
2009 Lippross V, Hermann S, Nagelmann N, Heselhaus J, Bohlen S, Kugel H, Deppe M, Sommer J, Bremer C, Nguyen H, Riess O, Hörsten Sv, Schäfers M, Reilmann R. In vivo assessment of neuronal dysfunction in rats transgenic for Huntington's disease using small animal FDG-PET and MRI – a 16 months follow-up study Aktuelle Neurologie. 36. DOI: 10.1055/s-0029-1238559  0.184
2012 Hölzner E, Baxa M, Nagelmann N, Marcegaglia M, Weber N, Benner S, Faber C, Motlik J, Reilmann R. C01 TRACK-TGHD MINIPIG—introduction of a longitudinal tgHD minipig phenotyping study using MRI, motor and cognitive endpoints Journal of Neurology, Neurosurgery & Psychiatry. 83: A15.2-A15. DOI: 10.1136/jnnp-2012-303524.48  0.181
2010 Ekwall C, Bohlen S, Reilmann R, Wiklund L. J02 Physical therapy for patients with Huntington's disease: effects of a treatment program and intercorrelation between outcome measures Journal of Neurology, Neurosurgery & Psychiatry. 81: A40.1-A40. DOI: 10.1136/JNNP.2010.222661.2  0.177
2024 Maetzler W, Correia Guedes L, Emmert KN, Kudelka J, Hildesheim HL, Paulides E, Connolly H, Davies K, Dilda V, Ahmaniemi T, Avedano L, Bouça-Machado R, Chambers M, Chatterjee M, Gallagher P, ... ... Reilmann R, et al. Fatigue-Related Changes of Daily Function: Most Promising Measures for the Digital Age. Digital Biomarkers. 8: 30-39. PMID 38510264 DOI: 10.1159/000536568  0.168
2023 Hinchliffe C, Rehman RZU, Branco D, Jackson D, Ahmaniemi T, Guerreiro T, Chatterjee M, Manyakov NV, Pandis I, Davies K, Macrae V, Aufenberg S, Paulides E, Hildesheim H, Kudelka J, ... ... Reilmann R, et al. Identification of Fatigue and Sleepiness in Immune and Neurodegenerative Disorders from Measures of Real-World Gait Variability. Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual International Conference. 2023: 1-4. PMID 38083383 DOI: 10.1109/EMBC40787.2023.10339956  0.164
2011 Bohlen S, Ekwall C, Wiklund L, Reilmann R. Huntington'sche Krankheit - Verbesserung der Gangsicherheit durch Physiotherapie Klinische Neurophysiologie. 42. DOI: 10.1055/s-0031-1272682  0.16
2020 Papoutsi M, Magerkurth J, Josephs O, Pépés SE, Ibitoye T, Reilmann R, Hunt N, Payne E, Weiskopf N, Langbehn D, Rees G, Tabrizi SJ. Activity or connectivity? A randomized controlled feasibility study evaluating neurofeedback training in Huntington's disease. Brain Communications. 2: fcaa049. PMID 32954301 DOI: 10.1093/braincomms/fcaa049  0.156
2021 Monje MHG, Fuller RLM, Cubo E, Mestre TA, Tan AH, Stout JC, Ali S, Chahine L, Dujardin K, Fitzer-Attas CJ, Youn J, Bloem BR, Horak FB, Merola A, Reilmann R, et al. Toward e-Scales: Digital Administration of the International Parkinson and Movement Disorder Society Rating Scales. Movement Disorders Clinical Practice. 8: 208-214. PMID 33553489 DOI: 10.1002/mdc3.13135  0.143
2012 Squitieri F, Landwehrmeyer B, Reilmann R, Rosser A, Garcia de Yebenes J, Prang A, Ivkovic J. Q07 Long-term safety and tolerability of pridopidine in patients with huntington's disease (HD): results of the mermaihd study open-label extension Journal of Neurology, Neurosurgery & Psychiatry. 83: A56.3-A57. DOI: 10.1136/Jnnp-2012-303524.177  0.136
2024 Hermle D, Schubert R, Barallon P, Ilg W, Schüle R, Reilmann R, Synofzik M, Traschütz A. Multifeature quantitative motor assessment of upper limb ataxia including drawing and reaching. Annals of Clinical and Translational Neurology. PMID 38590028 DOI: 10.1002/acn3.52024  0.12
2024 Reilmann R. Concern about Tominersen in Patients with Huntington's Disease. The New England Journal of Medicine. 390: 1058-1059. PMID 38478005 DOI: 10.1056/NEJMc2400161  0.12
2014 Weber N, Koch R, Reilmann R. G02 Longitudinal Development Of Cognitive Test Scores In Premanifest And Manifest Patients Of The Registry-cohort Journal of Neurology, Neurosurgery & Psychiatry. 85: A50-A50. DOI: 10.1136/jnnp-2014-309032.142  0.119
2009 van den Bogaard S, Bechtel N, Sturrock A, Jauffret C, Say M, Mills J, Archarya T, Langbehn D, Johnson H, Borowsky B, Durr A, Leavitt B, Roos R, Tabrizi S, Landwehrmeyer B, ... Reilmann R, et al. On Chorea – quantitative and objective analysis – cross-sectional results of the TRACK-HD Study Aktuelle Neurologie. 36. DOI: 10.1055/S-0029-1238519  0.099
2023 Graeber J, Warmerdam E, Aufenberg S, Bull C, Davies K, Dixon J, Emmert K, Judd C, Maetzler C, Reilmann R, Ng WF, Macrae V, Maetzler W, Kaduszkiewicz H. Technology acceptance of digital devices for home use: Qualitative results of a mixed methods study. Digital Health. 9: 20552076231181239. PMID 37361435 DOI: 10.1177/20552076231181239  0.091
2014 Nagelmann N, Frank F, Liebsch L, Schubert R, Wirsig M, Schramke S, Schuldenzucker V, Juhas S, Baxa M, Motlik J, Marcegaglia M, Holzner E, Faber C, Reilmann R. C12 Volumetry of Nucleus Caudatus, Lateral Ventricles and Cerebrum of Founder and Second Generation Libechov Transgenic HD Minipigs Journal of Neurology, Neurosurgery & Psychiatry. 85: A29-A29. DOI: 10.1136/jnnp-2014-309032.85  0.081
2007 Reilmann R, Holtbernd F, Bachmann R, Ringelstein E, Deppe M. Region specific fractional anisotropy in diffusion tensor MR imaging reveals EDSS correlation in patients with Multiple Sclerosis Aktuelle Neurologie. 34. DOI: 10.1055/s-2007-988003  0.066
2007 Beckmann H, Domschke K, Baune B, Reilmann R. Progressive supranuclear palsy misdiagnosed as depression and catatonic schizophrenia Aktuelle Neurologie. 34. DOI: 10.1055/s-2007-987654  0.046
2006 Reilmann R, Weckesser M, Ringelstein E. Bilateral prefrontal hypermetabolism in FDG-PET – a functional correlate of delirium tremens? Aktuelle Neurologie. 33. DOI: 10.1055/S-2006-953459  0.034
2014 Wirsig M, Schuldenzucker V, Schramke S, Frank F, Schubert R, Ott S, Marcegaglia M, Holzner E, Reilmann R. C17 Track TGHD Minipig - Startbox back and Forth Test Journal of Neurology, Neurosurgery & Psychiatry. 85: A30-A31. DOI: 10.1136/jnnp-2014-309032.90  0.028
Hide low-probability matches.